New Elite Feature: Chart Templates — Your indicators and design everywhere on Finviz

EUDA Health Holdings Ltd

Contributing Author

Recent Articles by EUDA Health Holdings Ltd

Mar-19	EUDA Announces Reverse Stock Split of its Ordinary Shares EUDA -15.19% GlobeNewswire
Mar-04	EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant EUDA GlobeNewswire
Jan-15	EUDA Health Announces Second Amendment to Streeterville Warrant Agreement EUDA GlobeNewswire
Jan-13	EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy Platform EUDA -13.93% GlobeNewswire
Jan-07	EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant Agreement EUDA +5.70% GlobeNewswire
Dec-30	EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital EUDA GlobeNewswire
Dec-29	EUDA Health to Launch EUDA Helixe 2.0 in January 2026 EUDA GlobeNewswire
Dec-23	EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen EUDA +41.18% GlobeNewswire
Dec-22	EUDA Integrates QB Utility Token to Create a Digital Health and Rewards Platform Across Its Healthcare Ecosystem EUDA -51.43% GlobeNewswire
Dec-08	EUDA Plans to Integrate QB Utility Token into Its Healthcare Ecosystem EUDA +8.46% GlobeNewswire
Dec-05	EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement EUDA -6.21% GlobeNewswire
Oct-23	EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock India EUDA -15.49% GlobeNewswire
Oct-20	EUDA Subsidiary CK Health Plus Secures Malaysia Direct Selling License, Strengthening Its Longevity Business Across Asia EUDA GlobeNewswire
Sep-10	EUDA Signs Letter of Intent to Potentially Acquire GO POSB EUDA -5.44% GlobeNewswire
Sep-04	EUDA Strategically Expands into T-Cell Immunotherapy - Strengthening Its Stem Cell Therapy Portfolio EUDA -9.09% GlobeNewswire
Aug-28	EUDA Signs Letter of Intent to Potentially Acquire Chemokine Pte Ltd EUDA GlobeNewswire
Aug-26	EUDA Expands Wellness Product Portfolio With A Next-Generation Immune Health Supplement EUDA -15.73% GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)